It's worth noting that GLP-1 receptor agonists should be used with caution in people with severe gastrointestinal disease, including severe gastroparesis, as these conditions may be exacerbated by further slowing of gastric emptying
Carcinogenesis 22 , 18711875 (2001)
Testing costs just $99 after your first month of treatment and provides actionable insights into whether semaglutide, tirzepatide, or a dual-compound approach may work best for your insulin resistance and weight loss goals
Still, side effects are possible for about 40% of people, including nausea, diarrhea, stomach pain, vomiting, constipation, heartburn, loss of appetite and cravings and an aversion to foods
Of course, how many calories you need to lose weight (or maintain) depends on a variety of factors like your gender, age, height, weight, and activity level
75 Although animal studies suggest the potential use of DPP4 inhibitors for SSc treatment, further clinical trials are needed to explore their effects on SSc patients